{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:07:51Z","timestamp":1767863271334,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PS09\/02670"],"award-info":[{"award-number":["PS09\/02670"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"crossref","award":["GRC2013-043"],"award-info":[{"award-number":["GRC2013-043"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jconrel.2016.07.048","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T01:23:05Z","timestamp":1469841785000},"page":"263-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer"],"prefix":"10.1016","volume":"238","author":[{"given":"Erea","family":"Borrajo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Abellan-Pose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atenea","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6393-6469","authenticated-orcid":false,"given":"Marcos","family":"Garcia-Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi","family":"Csaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-9567","authenticated-orcid":false,"given":"Maria J.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-4202","authenticated-orcid":false,"given":"Anxo","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.07.048_bb0005","series-title":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide, IARC CancerBase No. 11 [Internet]","author":"Ferlay","year":"2013"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3180","article-title":"Treating metastatic cancer with nanotechnology","volume":"12","author":"Schroeder","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc863","article-title":"Lymphangiogenesis and cancer metastasis","volume":"2","author":"Stacker","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0025","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2174\/1381612822666151216150809","article-title":"Lymphatic targeting of nanosystems for anticancer drug therapy","volume":"22","author":"Abellan-Pose","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2012.01.038","article-title":"Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis","volume":"159","author":"Rafi","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2013.07.005","article-title":"Polymeric micelles for enhanced lymphatic drug delivery to treat metastatic tumors","volume":"171","author":"Qin","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0040","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1021\/nn5070259","article-title":"Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled nanocarriers","volume":"9","author":"Cabral","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1471-2407-14-329","article-title":"Small-sized polymeric micelles incorporating docetaxel suppress distant metastases in the clinically-relevant 4T1 mouse breast cancer model","volume":"14","author":"Li","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2217\/nnm.11.134","article-title":"Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles.","volume":"7","author":"Estella-Hermoso de Mendoza","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0055","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.biomaterials.2012.11.038","article-title":"Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles.","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/1061186X.2014.897708","article-title":"Preparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targeting","volume":"22","author":"Tan","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2006.01.001","article-title":"Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases","volume":"28","author":"Lu","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0070","article-title":"Safe lipid nanocapsule-based gel technology to target lymph nodes and combat mediastinal metastases from an orthotopic non-small-cell lung cancer model in SCID-CB17 mice","volume":"1","author":"Wauthoz","year":"2015","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2014.04.051","article-title":"Nano-chemotherapeutics: Maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers","volume":"193","author":"Ryan","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0080","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/jps.21970","article-title":"Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery","volume":"99","author":"Rao","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0085","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/10611860802475688","article-title":"Lymphatic targeting of zidovudine using surface-engineered liposomes","volume":"16","author":"Kaur","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biomaterials.2005.05.082","article-title":"The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes","volume":"27","author":"Moghimi","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2014.03.012","article-title":"Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy","volume":"183","author":"Kaminskas","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1515\/ejnm-2015-0003","article-title":"Passive and specific targeting of lymph nodes: the influence of the administration route","volume":"7","author":"Pitorre","year":"2015","journal-title":"Eur. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2013.03.037","article-title":"A new potential nano-oncological therapy based on polyamino acid nanocapsules","volume":"169","author":"Gonzalo","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijpharm.2015.02.028","article-title":"Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative","volume":"483","author":"Lollo","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2016.05.034","article-title":"Polyaminoacid nanocapsules for drug delivery to the lymphatic system: effect of the particle size","volume":"509","author":"Abellan-Pose","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0378-4347(98)00566-0","article-title":"Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography","volume":"724","author":"Lee","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4143\/crt.2006.38.4.234","article-title":"Mouse orthotopic lung cancer model induced by PC14PE6","volume":"38","author":"Cui","year":"2006","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0130","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1007\/s11095-012-0818-1","article-title":"Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method?","volume":"29","author":"Liu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0135","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.3390\/molecules17055564","article-title":"Fluorescent nanoprobes dedicated to in vivo imaging: from preclinical validations to clinical translation","volume":"17","author":"M\u00e9rian","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0005-2736(97)00122-3","article-title":"Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose","author":"Oussoren","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0145","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1023\/A:1008290406221","article-title":"Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP)","volume":"8","author":"Vanhoefer","year":"1997","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0150","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1021\/bm800298u","article-title":"Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.","volume":"9","author":"Lozano","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/02652048.2012.714411","article-title":"Intracellular delivery of docetaxel using freeze-dried polysaccharide nanocapsules.","volume":"30","author":"Lozano","year":"2013","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0160","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejpb.2012.10.017","article-title":"Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules","volume":"83","author":"Torrecilla","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0165","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ejpb.2013.08.001","article-title":"Poly-l-asparagine nanocapsules as anticancer drug delivery vehicles","volume":"85","author":"Rivera-Rodr\u00edguez","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2013.09.038","article-title":"In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery","volume":"458","author":"Rivera-Rodriguez","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejps.2013.05.008","article-title":"Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery","volume":"49","author":"Oyarzun-Ampuero","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejpb.2014.02.004","article-title":"Polyglutamic acid-PEG nanocapsules as long circulated carriers for the delivery of docetaxel","volume":"87","author":"Lollo","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08982109709035487","article-title":"Lymphatic uptake and biodistribution of liposomes after subcutaneous injection I. Influence of the anatomical site of injection","volume":"7","author":"Oussoren","year":"1997","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0169-409X(01)00154-5","article-title":"Liposomes to target the lymphatics by subcutaneous administration","volume":"50","author":"Oussoren","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0195","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.addr.2013.10.007","article-title":"Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: illustration with the case of taxane therapeutics","volume":"71","author":"Reddy","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0200","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/sj.bjc.6602479","article-title":"NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel","volume":"92","author":"Hamaguchi","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2005.09.033","article-title":"Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane","volume":"109","author":"Singer","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0210","doi-asserted-by":"crossref","first-page":"128ra39","DOI":"10.1126\/scitranslmed.3003651","article-title":"Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile","volume":"4","author":"Hrkach","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0215","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejps.2011.09.016","article-title":"Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20","volume":"45","author":"Weiszh\u00e1r","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0220","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11095-009-0024-y","article-title":"Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice","volume":"27","author":"Hureaux","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0225","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.biomaterials.2011.10.061","article-title":"Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models","volume":"33","author":"Ernsting","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0230","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00280-006-0287-5","article-title":"Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model","volume":"59","author":"Devalapally","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.048_bb0235","first-page":"3601","article-title":"2\u2032-(2-Bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model","volume":"9","author":"Peng","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0240","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2010.02.029","article-title":"Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles.","volume":"144","author":"Zhigaltsev","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.048_bb0245","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biomaterials.2008.09.014","article-title":"The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma","volume":"30","author":"Xu","year":"2009","journal-title":"Biomaterials"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916304941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916304941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T15:13:41Z","timestamp":1572534821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916304941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":49,"alternative-id":["S0168365916304941"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.048","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}